DuPont de Nemours (DD)
(Delayed Data from NYSE)
$79.03 USD
-0.56 (-0.70%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $79.02 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
DuPont de Nemours (DD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$92.17 | $103.00 | $80.00 | 15.81% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for DuPont de Nemours comes to $92.17. The forecasts range from a low of $80.00 to a high of $103.00. The average price target represents an increase of 15.81% from the last closing price of $79.59.
Analyst Price Targets (12)
Broker Rating
DuPont de Nemours currently has an average brokerage recommendation (ABR) of 1.93 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.93 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 53.33% and 6.67% of all recommendations. A month ago, Strong Buy made up 53.33%, while Buy represented 6.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/DD.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 9 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.93 | 1.93 | 1.93 | 1.93 | 2.47 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/29/2024 | UBS | Joshua Spector | Strong Buy | Strong Buy |
5/28/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/24/2024 | Wells Fargo Securities | Michael J Sison | Hold | Strong Buy |
5/24/2024 | BMO Capital Markets | John P Mcnulty | Hold | Strong Buy |
5/17/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/2/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Hold | Hold |
5/2/2024 | Mizuho SecuritiesUSA | John Roberts | Strong Buy | Strong Buy |
5/2/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | Not Identified | Not Identified | Not Available | Hold |
3/1/2024 | Not Identified | Not Identified | Not Available | Hold |
2/7/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.93 |
ABR (Last week) | 1.93 |
# of Recs in ABR | 15 |
Average Target Price | $92.17 |
LT Growth Rate | 8.80% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 236 of 252 |
Current Quarter EPS Est: | 0.85 |